Whalen Wealth Management Inc. Buys New Position in Oscar Health, Inc. (NYSE:OSCR)

Whalen Wealth Management Inc. purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 49,823 shares of the company’s stock, valued at approximately $670,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the second quarter worth approximately $78,000. KBC Group NV increased its stake in Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares in the last quarter. ORG Wealth Partners LLC acquired a new position in Oscar Health during the fourth quarter worth $100,000. Amalgamated Bank lifted its stake in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after buying an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors acquired a new position in shares of Oscar Health during the third quarter valued at about $142,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Oscar Health

In related news, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now directly owns 102,598 shares in the company, valued at approximately $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

Oscar Health Stock Performance

OSCR stock opened at $16.30 on Thursday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market cap of $4.03 billion, a PE ratio of -271.57, a P/E/G ratio of 0.63 and a beta of 1.70. The business has a 50 day moving average of $15.17 and a 200-day moving average of $16.81. Oscar Health, Inc. has a 12-month low of $10.84 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter last year, the company earned ($0.29) EPS. As a group, sell-side analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OSCR has been the topic of several recent research reports. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Finally, Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.